Cel Sci Corporation (CVM)

[georgebailey]

Ill add some catalysts
-new licensing deals in more geograhies
-upfront licensing payments
-Takeover speculation(we are undervalued)
-Tutes gain interest and agree undervalued taking a larger stake. This preceeds a public 13f filing and evidenced by price and volume increases.
-CVM planning a secondary at a certain minimum price, the tutes will work the stock and get it to that minimum.
-Another FDA prelim analysis emphasizing no safety concerns and the study may proceed.
-additions/replacements at the C level or BOD.

Bottom line we are undervalued and it wont stay this way.